Advertisement
Advertisement

TARA

TARA logo

Protara Therapeutics, Inc. Common Stock

4.00
USD
Sponsored
-0.04
-0.87%
Jun 25, 12:39 UTC -4
Open

TARA Earnings Reports

Positive Surprise Ratio

TARA beat 28 of 42 last estimates.

67%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.33
Implied change from Q1 26 (Revenue/ EPS)
--
/
+6.45%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-5.71%

Protara Therapeutics, Inc. Common Stock earnings per share and revenue

On May 13, 2026, TARA reported earnings of -0.31 USD per share (EPS) for Q1 26, beating the estimate of -0.38 USD, resulting in a 18.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.97% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an increase of 6.45% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Protara Therapeutics, Inc. Common Stock reported EPS of -$0.31, beating estimates by 18.81%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.97%, changed from $5.15 before the earnings release to $5.20 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 6 analysts, Protara Therapeutics, Inc. Common Stock is expected to report EPS of -$0.33 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement